FERRARESI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 4.821
AS - Asia 2.371
EU - Europa 1.205
SA - Sud America 352
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 49
OC - Oceania 5
Totale 8.853
Nazione #
US - Stati Uniti d'America 4.702
SG - Singapore 857
CN - Cina 619
VN - Vietnam 315
BR - Brasile 270
DE - Germania 245
UA - Ucraina 219
IT - Italia 203
HK - Hong Kong 175
GB - Regno Unito 135
TR - Turchia 127
FI - Finlandia 76
FR - Francia 71
CA - Canada 69
BD - Bangladesh 64
JP - Giappone 61
IN - India 55
RU - Federazione Russa 52
SE - Svezia 48
MX - Messico 35
PL - Polonia 34
AR - Argentina 24
BE - Belgio 23
ZA - Sudafrica 22
ES - Italia 20
IQ - Iraq 20
CO - Colombia 16
EC - Ecuador 15
ID - Indonesia 15
NL - Olanda 13
PK - Pakistan 13
LT - Lituania 12
AT - Austria 10
IE - Irlanda 9
VE - Venezuela 9
MA - Marocco 8
CZ - Repubblica Ceca 7
CR - Costa Rica 6
RO - Romania 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
PE - Perù 5
AL - Albania 4
CL - Cile 4
EG - Egitto 4
JO - Giordania 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
IR - Iran 3
JM - Giamaica 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
SI - Slovenia 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
KE - Kenya 2
LY - Libia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RS - Serbia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LV - Lettonia 1
MV - Maldive 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 8.802
Città #
Singapore 559
Ashburn 461
Woodbridge 353
San Jose 344
Fairfield 313
Chandler 249
Santa Clara 227
Houston 225
Jacksonville 225
Ann Arbor 224
Beijing 223
Hong Kong 165
Seattle 150
Council Bluffs 125
Wilmington 125
Dallas 119
New York 115
Cambridge 108
Ho Chi Minh City 104
Hanoi 80
Ferrara 79
Boardman 74
Los Angeles 73
Izmir 72
Munich 69
Nanjing 67
Tokyo 60
Princeton 48
The Dalles 42
Lauterbourg 40
Shanghai 32
Warsaw 32
Buffalo 28
Mexico City 26
Milan 26
São Paulo 26
Brussels 23
Chicago 23
Dearborn 23
San Diego 23
Shenyang 23
Orem 21
Da Nang 20
Toronto 20
Jiaxing 19
Frankfurt am Main 18
Montreal 18
Tianjin 18
London 17
Jinan 16
Nanchang 16
Bremen 15
Brooklyn 15
Helsinki 15
Turku 15
Baghdad 14
Phoenix 14
Düsseldorf 13
Hebei 13
Haiphong 12
Atlanta 11
Auburn Hills 11
Chennai 11
Falls Church 11
Florence 11
Johannesburg 11
Manchester 11
Rio de Janeiro 11
Belo Horizonte 10
Denver 10
Hefei 10
Philadelphia 10
Amsterdam 9
Jakarta 9
Nuremberg 9
Ottawa 9
Redwood City 9
San Francisco 9
Stockholm 9
Washington 9
Bologna 8
Boston 7
Charlotte 7
Curitiba 7
Dortmund 7
Kyiv 7
Mountain View 7
Norwalk 7
Poplar 7
Porto Alegre 7
San Mateo 7
Vienna 7
Brno 6
Changsha 6
Dublin 6
Hải Dương 6
Istanbul 6
Moscow 6
Tashkent 6
Thái Nguyên 6
Totale 6.045
Nome #
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 254
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 253
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 253
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 249
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 229
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 228
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 225
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 217
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 212
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 207
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 205
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 205
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 199
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 199
Factor IX propeptide mutation and life threatening bleeding 195
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 194
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 192
Factor V gene mutations (R2 gene) are associated with coronary artery disease inelderly people 184
Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism 183
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 181
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 181
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 179
Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency 178
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease 174
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 174
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 174
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 172
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 171
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 167
Factor VIIa levels, gene polymorphism and plasma lipids in subjects with or without angiographically proven coronary artery disease 166
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 165
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 164
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 162
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 161
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report 159
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 158
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report 158
Non-conventional therapeutic strategies for inherited disorders of hemostasis 157
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 156
Modulation Of Factor VII Expression By Repeat And Sequence Variations In The Intron 7 Of FVII Gene: Population And In Vitro Studies 148
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 122
Strong contribution of FVII genotypes to activated FVII levels and differences in genotype frequencies in northern and southern European countries 114
The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. 111
The asymptomatic carriership of thrombophilic defects is associated with frequent genotypes of the fibrinogen gene cluster. 108
null 103
Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype 100
Rescue of a panel of Hemophilia A-causing 5’ss splicing mutations by unique Exon-specific U1snRNA variants 93
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 87
null 82
null 78
null 73
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction 72
null 61
null 61
Totale 8.853
Categoria #
all - tutte 38.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.033


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022400 0 0 34 23 21 9 24 15 9 32 62 171
2022/2023525 56 53 16 79 75 79 18 41 63 2 23 20
2023/2024354 31 26 7 6 30 78 10 26 9 19 11 101
2024/20251.123 29 20 115 36 147 128 9 24 163 113 184 155
2025/20263.469 375 131 302 452 534 250 400 192 303 311 119 100
2026/2027342 78 161 103 0 0 0 0 0 0 0 0 0
Totale 8.853